Real-time enrollment status for this macular degeneration clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06373731 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 360 participants |
| Active Locations | 34 sites in the US |
| Sponsor | Stealth BioTherapeutics Inc. |
| Last Updated on CT.gov | November 17, 2025 (Nov 17, 2025) |
As of March 2, 2026: Clinical trial NCT06373731 is currently active_not_recruiting participants. This clinical trial study for macular degeneration is not currently accepting new participants at 34 locations across the United States. The study is sponsored by Stealth BioTherapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06373731 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06373731 was last updated Nov 17, 2025 (November 17, 2025). HelloStudys verifies this status automatically.